Scope Fluidics SA
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.
Market Cap & Net Worth: Scope Fluidics SA (SCP)
Scope Fluidics SA (WAR:SCP) has a market capitalization of $92.96 Million (zł386.54 Million) as of March 19, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #20981 globally and #115 in its home market, demonstrating a -4.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scope Fluidics SA's stock price zł141.80 by its total outstanding shares 2725930 (2.73 Million).
Scope Fluidics SA Market Cap History: 2017 to 2026
Scope Fluidics SA's market capitalization history from 2017 to 2026. Data shows growth from $9.51 Million to $92.96 Million (27.00% CAGR).
Scope Fluidics SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scope Fluidics SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
820.72x
Scope Fluidics SA's market cap is 820.72 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
1.64x
Scope Fluidics SA's market cap is 1.64 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $9.51 Million | $1.80K | -$4.17 Million | 5281.01x | N/A |
| 2022 | $136.03 Million | $404.00K | $318.49 Million | 336.71x | 0.43x |
| 2023 | $128.49 Million | $516.00K | -$18.79 Million | 249.02x | N/A |
| 2024 | $107.51 Million | $131.00K | $65.42 Million | 820.72x | 1.64x |
Competitor Companies of SCP by Market Capitalization
Companies near Scope Fluidics SA in the global market cap rankings as of March 19, 2026.
Key companies related to Scope Fluidics SA by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Scope Fluidics SA Historical Marketcap From 2017 to 2026
Between 2017 and today, Scope Fluidics SA's market cap moved from $9.51 Million to $ 92.96 Million, with a yearly change of 27.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł92.96 Million | +4.11% |
| 2025 | zł89.29 Million | -16.95% |
| 2024 | zł107.51 Million | -16.33% |
| 2023 | zł128.49 Million | -5.54% |
| 2022 | zł136.03 Million | +52.13% |
| 2021 | zł89.42 Million | +1.04% |
| 2020 | zł88.50 Million | +125.00% |
| 2019 | zł39.33 Million | +300.00% |
| 2018 | zł9.83 Million | +3.45% |
| 2017 | zł9.51 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Scope Fluidics SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $92.96 Million USD |
| MoneyControl | $92.96 Million USD |
| MarketWatch | $92.96 Million USD |
| marketcap.company | $92.96 Million USD |
| Reuters | $92.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.